Meritxell Arenas1, David Gomez2, Sebastià Sabater3, Angeles Rovirosa4, Albert Biete4, Jordi Colomer5. 1. Department of Radiation Oncology, Hospital Universitari Sant Joan de Reus, Institut d'Investigacions Sanitàries Pere Virgili (IISPV), Universitat Rovira i Virgili (URV), Tarragona, Spain. 2. Department of Radiation Oncology, Hospital Universitari Sant Joan de Reus, IISPV, Tarragona, Spain. 3. Department of Radiation Oncology, Complejo Hospitalario Universitario de Albacete, Spain. 4. Department of Radiation Oncology, Hospital Universitari Clínic de Barcelona, Spain. 5. Hospital Universitari Sant Joan de Reus and Group SAGESSA (Assistència Sanitària i Social), Tarragona, Spain.
Abstract
BACKGROUND: The concept of satellite radiotherapy originates in countries whose populations are largely dispersed in order to treat homogenously the population by a unique fixed team. AIM: This report describes the creation and management of a satellite radiotherapy unit in Spain (RUTE-Radiotherapy Unit, Terres de l'Ebre). It is managed by the Radiation Oncology Department at Hospital Universitari Sant Joan de Reus. We report the benefit gained in the comfort of patients and the economic benefit gained by reducing the expense of transport for the health care system. MATERIALS AND METHODS: RUTE is equipped with a linear accelerator. A team of 10 physicians, specialised in different oncology pathologies, travel to RUTE on a rotational basis from the main Radiation Oncology Department. Simulation and planning of treatment is managed at the Radiation Oncology Department in Reus. Patients from RUTE only have to visit the centre in Reus once throughout the treatment process. RESULTS: Since August 2008, 1500 patients have completed treatment in the satellite unit. The implementation of RUTE has greatly improved the comfort of patients and along with that, there have been important savings in transport costs to the regional health care system. CONCLUSIONS: Despite the high technological requirements of our speciality, decentralising radiotherapy is feasible. We can guarantee the highest standards of treatment with no differences from attending the main centre. It implies a clear benefit for the comfort of the patients and an economic benefit by decreasing transport costs.
BACKGROUND: The concept of satellite radiotherapy originates in countries whose populations are largely dispersed in order to treat homogenously the population by a unique fixed team. AIM: This report describes the creation and management of a satellite radiotherapy unit in Spain (RUTE-Radiotherapy Unit, Terres de l'Ebre). It is managed by the Radiation Oncology Department at Hospital Universitari Sant Joan de Reus. We report the benefit gained in the comfort of patients and the economic benefit gained by reducing the expense of transport for the health care system. MATERIALS AND METHODS: RUTE is equipped with a linear accelerator. A team of 10 physicians, specialised in different oncology pathologies, travel to RUTE on a rotational basis from the main Radiation Oncology Department. Simulation and planning of treatment is managed at the Radiation Oncology Department in Reus. Patients from RUTE only have to visit the centre in Reus once throughout the treatment process. RESULTS: Since August 2008, 1500 patients have completed treatment in the satellite unit. The implementation of RUTE has greatly improved the comfort of patients and along with that, there have been important savings in transport costs to the regional health care system. CONCLUSIONS: Despite the high technological requirements of our speciality, decentralising radiotherapy is feasible. We can guarantee the highest standards of treatment with no differences from attending the main centre. It implies a clear benefit for the comfort of the patients and an economic benefit by decreasing transport costs.
Entities:
Keywords:
Decentralisation radiation therapy; Health care system; Satellite unit
Authors: W J Mackillop; P A Groome; J Zhang-Solomons; Y Zhou; D Feldman-Stewart; L Paszat; P Dixon; E J Holowaty; B J Cummings Journal: J Clin Oncol Date: 1997-03 Impact factor: 44.544
Authors: Neil Maizlish; James Woodcock; Sean Co; Bart Ostro; Amir Fanai; David Fairley Journal: Am J Public Health Date: 2013-02-14 Impact factor: 9.308
Authors: A Rodríguez; M Arenas; P C Lara; J López-Torrecilla; M Algara; A Conde; H Pérez-Montero; J L Muñoz; P Peleteiro; M J Pérez-Calatayud; J Contreras; C Ferrer Journal: Clin Transl Oncol Date: 2019-04-03 Impact factor: 3.405
Authors: A Rodríguez; M Algara; D Monge; J López-Torrecilla; F Caballero; R Morera; R Escó; H Pérez-Montero; C Ferrer; P C Lara Journal: Clin Transl Oncol Date: 2017-08-03 Impact factor: 3.405
Authors: Christian H Flores-Balcázar; Ma L Flores-Luna; Cynthia M Villarreal-Garza; Juan E Bargalló-Rocha Journal: Rep Pract Oncol Radiother Date: 2020-02-21